Clinical manifestations in the study population
| Clinical manifestations | Entire APS population (n = 284) | PAPS (n = 159) | SLE with APS (n = 97) | p Value | ||||
|---|---|---|---|---|---|---|---|---|
| Values are per cent. | ||||||||
| APS, antiphospholipid syndrome; CVA, cerebrovascular accident; PAPS, primary antiphospholipid syndrome; SLE, systemic lupus erythematosus; TIA, transient ischaemic attack. | ||||||||
| Deep venous thrombosis | 57.4 | 52.2 | 59.8 | NS | ||||
| Arterial thrombosis | 48.6 | 45.3 | 56.7 | NS | ||||
| Recurrent pregnancy loss | 27.7 | 34.6 | 19.8 | <0.03 | ||||
| TIA/CVA | 35.2 | 35.8 | 39.2 | NS | ||||
| Myocardial infarction | 7.4 | 5.7 | 10.3 | NS | ||||
| Epilepsy | 9.9 | 6.9 | 15.5 | <0.03 | ||||
| Migraine | 18.0 | 20.8 | 14.4 | NS | ||||
| Cardiac valve vegetations | 6.0 | 4.4 | 9.3 | NS | ||||
| Cardiac valve thickening | 18.0 | 17.6 | 19.6 | NS | ||||
| Overall cardiac valve abnormalities | 21.1 | 18.2 | 27.8 | NS | ||||
| Livedo reticularis | 15.8 | 11.3 | 25.8 | <0.005 | ||||
| Thrombocytopenia | 28.5 | 22.6 | 40.2 | <0.005 | ||||
| Autoimmune haemolytic anaemia | 10.2 | 7.5 | 17.5 | <0.02 | ||||